ADVENTRX Pharmaceuticals (ANX)
ADVENTRX Pharmaceuticals Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 25, 2012 | 0.5301 | 0.5495 | 0.5301 | 0.535 | 76442 |
| May 24, 2012 | 0.54 | 0.55 | 0.5328 | 0.54 | 270060 |
| May 23, 2012 | 0.55 | 0.55 | 0.53 | 0.5412 | 127448 |
| May 22, 2012 | 0.5375 | 0.55 | 0.519 | 0.5472 | 455742 |
| May 21, 2012 | 0.5301 | 0.54 | 0.5222 | 0.525 | 142691 |
| May 18, 2012 | 0.52 | 0.56 | 0.52 | 0.54 | 1160631 |
| May 17, 2012 | 0.53 | 0.54 | 0.52 | 0.5301 | 211124 |
| May 16, 2012 | 0.53 | 0.54 | 0.53 | 0.5301 | 246779 |
| May 15, 2012 | 0.54 | 0.54 | 0.527 | 0.54 | 365830 |
| May 14, 2012 | 0.54 | 0.5481 | 0.53 | 0.54 | 333331 |
| May 11, 2012 | 0.56 | 0.56 | 0.52 | 0.54 | 1147452 |
| May 10, 2012 | 0.55 | 0.569 | 0.55 | 0.569 | 134674 |
| May 9, 2012 | 0.585 | 0.60 | 0.541 | 0.55 | 542692 |
| May 8, 2012 | 0.63 | 0.63 | 0.5801 | 0.5899 | 466919 |
| May 7, 2012 | 0.58 | 0.595 | 0.58 | 0.59 | 121137 |
| May 4, 2012 | 0.575 | 0.598 | 0.5733 | 0.59 | 281906 |
| May 3, 2012 | 0.60 | 0.60 | 0.575 | 0.575 | 212406 |
| May 2, 2012 | 0.625 | 0.625 | 0.58 | 0.59 | 447482 |
| May 1, 2012 | 0.595 | 0.605 | 0.5801 | 0.5975 | 258833 |
| April 30, 2012 | 0.58 | 0.595 | 0.5782 | 0.5899 | 100986 |
| April 27, 2012 | 0.595 | 0.595 | 0.572 | 0.58 | 278726 |
| April 26, 2012 | 0.585 | 0.60 | 0.573 | 0.58 | 383053 |
| April 25, 2012 | 0.60 | 0.60 | 0.582 | 0.585 | 229466 |
| April 24, 2012 | 0.59 | 0.60 | 0.58 | 0.60 | 197808 |
| April 23, 2012 | 0.6001 | 0.61 | 0.59 | 0.5903 | 235753 |
| April 20, 2012 | 0.59 | 0.6197 | 0.59 | 0.61 | 154064 |
| April 19, 2012 | 0.597 | 0.6199 | 0.5915 | 0.60 | 107947 |
| April 18, 2012 | 0.60 | 0.61 | 0.5922 | 0.60 | 226465 |
| April 17, 2012 | 0.6026 | 0.62 | 0.6026 | 0.61 | 131180 |
| April 16, 2012 | 0.64 | 0.65 | 0.60 | 0.613 | 324179 |
| April 13, 2012 | 0.65 | 0.65 | 0.617 | 0.64 | 96226 |
| April 12, 2012 | 0.612 | 0.65 | 0.6115 | 0.63 | 266698 |
| April 11, 2012 | 0.61 | 0.625 | 0.61 | 0.615 | 244849 |
| April 10, 2012 | 0.61 | 0.63 | 0.6001 | 0.61 | 333757 |
| April 9, 2012 | 0.6601 | 0.67 | 0.625 | 0.6399 | 205598 |
| April 5, 2012 | 0.67 | 0.6798 | 0.65 | 0.6516 | 192953 |
| April 4, 2012 | 0.6755 | 0.688 | 0.66 | 0.67 | 385785 |
| April 3, 2012 | 0.6501 | 0.6837 | 0.6501 | 0.6751 | 334664 |
| April 2, 2012 | 0.6761 | 0.70 | 0.6751 | 0.70 | 299365 |
| March 30, 2012 | 0.69 | 0.7004 | 0.68 | 0.69 | 341753 |
| March 29, 2012 | 0.68 | 0.69 | 0.675 | 0.69 | 189106 |
| March 28, 2012 | 0.68 | 0.69 | 0.67 | 0.6755 | 384428 |
| March 27, 2012 | 0.70 | 0.70 | 0.6606 | 0.6726 | 437441 |
| March 26, 2012 | 0.6966 | 0.7102 | 0.68 | 0.69 | 440867 |
| March 23, 2012 | 0.73 | 0.73 | 0.6815 | 0.69 | 493887 |
| March 22, 2012 | 0.69 | 0.72 | 0.67 | 0.71 | 1301500 |
| March 21, 2012 | 0.63 | 0.7062 | 0.624 | 0.6849 | 2915785 |
| March 19, 2012 | 0.64 | 0.65 | 0.61 | 0.6201 | 757687 |
| March 16, 2012 | 0.565 | 0.688 | 0.565 | 0.6387 | 2296489 |
| March 15, 2012 | 0.60 | 0.60 | 0.5795 | 0.59 | 248800 |
ANX News
Bio amazing. $ROSG truly a run for the ages. Just holding my small bios $ABIO and $ANX. Be interesting to see if ASCO conference pops them.
about 3 days ago by GarethSoloway
about 3 days ago by GarethSoloway
ADVENTRX Pharmaceuticals to Sponsor & Present at the Martin Center's 2012 Sickle Cell Disease Conference
Apr 16, 8:00AM PR Newswire
Apr 16, 8:00AM PR Newswire
RT @VistaPResearch $ANX Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals; $3.50 Target Price http://stks.co/2zLU
about 67 days ago by StockCowboy
about 67 days ago by StockCowboy
Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price
Mar 21, 9:15AM PR Newswire
Mar 21, 9:15AM PR Newswire
@adamfeuerstein $ANX is ABSOLUTE GARBAGE ! All they do is print paper and pay out banking fees. Culley is a JOKE!!
about 73 days ago by Bullbear123
about 73 days ago by Bullbear123
@StockCowboy $ANX Probably won't have a repeat tomorrow. 150M shelf offering.
about 80 days ago by Random_Walk
about 80 days ago by Random_Walk
RT @GarethSoloway Nice day on $ANX. Market otherwise so quiet. Volume 71.5M. Nuts.
about 80 days ago by InTheMoneyStocks
about 80 days ago by InTheMoneyStocks
ADVENTRX Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference on February 14
Feb 07, 8:00AM PR Newswire
Feb 07, 8:00AM PR Newswire
Biotech Sector on the Upswing -- Dendreon and ADVENTRX Pharmaceuticals Looking Strong
Jan 31, 8:20AM Marketwire
Jan 31, 8:20AM Marketwire
Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.; $3.50 Target Price
Dec 15, 9:21AM Benzinga
Dec 15, 9:21AM Benzinga
ADVENTRX (ANX) Discusses ANX-188 Phase 3 Structure w/ FDA; Additional Info Needed for Finalization
Dec 01, 8:40AM Street Insider
Dec 01, 8:40AM Street Insider
Speculative Healthcare Companies IntelGenx and Adventrx Begin to Gain Ground
Nov 15, 8:16AM Marketwire
Nov 15, 8:16AM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ANX | 0.535 | -0.01 | -0.93% | 25.53M |
| ANW | 5.27 | +0.01 | +0.19% | 243.63M |
| ANV | 27.47 | -0.20 | -0.72% | 2.463B |
| ASEI | 49.46 | +1.29 | +2.68% | 441.18M |
| ASCMA | 52.78 | +1.12 | +2.17% | 710.95M |
| ASCA | 18.42 | +0.13 | +0.71% | 605.47M |
| ASBC | 12.76 | -0.04 | -0.31% | 2.229B |
| ASA | 22.96 | +0.22 | +0.97% | |
| ARX | 6.54 | +0.01 | +0.15% | 554.72M |
| ARWRD | 4.120 | -0.05 | -1.20% |